Decreases in serum levels of S100 may predict response to therapy in melanoma patients treated with a polyvalent melanoma vaccine

被引：0
|
作者：
Bar, A [1 ]
Amin, P [1 ]
Reynolds, S [1 ]
Shapiro, R [1 ]
Roses, D [1 ]
Harris, M [1 ]
Bystryn, J [1 ]
机构：
[1] NYU, Sch Med, New York, NY USA
来源：
JOURNAL OF INVESTIGATIVE DERMATOLOGY | 2001年 / 117卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
901
引用
收藏
页码：540 / 540
页数：1
相关论文
共 50 条
  • [31] Serum levels of melanoma-inhibiting activity do not predict relapse in melanoma patients
    Klimek, VM
    Williams, L
    Chapman, PB
    CYTOKINES CELLULAR & MOLECULAR THERAPY, 2002, 7 (02) : 71 - 74
  • [32] Low baseline levels of NK cells may predict a positive response to ipilimumab in melanoma therapy
    Tietze, Julia K.
    Angelova, Daniela
    Heppt, Markus V.
    Ruzicka, Thomas
    Berking, Carola
    EXPERIMENTAL DERMATOLOGY, 2017, 26 (07) : 622 - 629
  • [33] Serum S100, melanoma inhibiting activity protein (MIA), beta-2 microglobulin and lactate dehydrogenase (LDH) in stage IV melanoma patients treated with biochemotherapy
    Cao, Maria Gonzalez
    Malvhey, Josep
    Auge, Jose Maria
    Marti, Rosa
    Castel, Teresa
    Molina, Rafael
    Puig, Susana
    ANNALS OF ONCOLOGY, 2004, 15 : 204 - 204
  • [34] CLINICAL-SIGNIFICANCE OF SERUM S100 IN METASTATIC MALIGNANT-MELANOMA
    GUO, HB
    STOFFELWAGNER, B
    BIERWIRTH, T
    MEZGER, J
    KLINGMULLER, D
    EUROPEAN JOURNAL OF CANCER, 1995, 31A (06) : 924 - 928
  • [35] Comparison of S100 protein and MIA protein as serum marker for malignant melanoma
    Djukanovic, D
    Hofmann, U
    Sucker, A
    Rittgen, W
    Schadendorf, D
    ANTICANCER RESEARCH, 2000, 20 (3B) : 2203 - 2207
  • [36] Comparison of the serum tumor markers S100 and melanoma inhibitory activity (MIA) in the monitoring of melanoma patients undergoing dendritic cell vaccination
    Schliep, S.
    Schliep, K.
    Erdmann, M.
    Koch, H.
    Schuler, G.
    Schuler-Thurner, B.
    EXPERIMENTAL DERMATOLOGY, 2010, 19 (02) : 221 - 221
  • [37] Elevated serum levels of S100 and survival in metastatic malignant melanoma (vol 75, pg 1373, 1996)
    Atzpodien, J
    Buer, J
    BRITISH JOURNAL OF CANCER, 1998, 77 (04) : 681 - 681
  • [38] Elevated serum levels of S100 and survival in metastatic malignant melanoma (vol 75, pg 1373, 1997)
    Atzpodien, J
    Buer, J
    BRITISH JOURNAL OF CANCER, 1998, 77 (05) : 854 - 854
  • [39] Expression and clinical significance of S100 family genes in patients with melanoma
    Xiong, Ting-feng
    Pan, Fu-qiang
    Li, Dong
    MELANOMA RESEARCH, 2019, 29 (01) : 23 - 29
  • [40] Evaluation of the Elecsys S100 immumoassay in patients with malignant melanoma.
    Alber, B
    Hein, R
    Luppa, P
    CLINICAL CHEMISTRY, 2004, 50 (06) : A78 - A78
12345